-
Even the savviest Medicare drug plan shoppers can get a shock when they fill prescriptions: That great deal on medications in fall is no bargain after prices go up as much as 8% by winter.
-
The move comes just days before a U.S. rule was set to go into effect allowing for bulk importation of drugs from Canada. Trump promised it would lower costs and be a "game changer" for seniors.
-
Industry experts say Florida is likely to be the first state to win federal approval for a drug importation plan — something that could occur before the November election.
-
Two nearly identical drug implants have very different prices. The one for kids has a list price of $37,300. For adults, it's $4,400. A dad fought for his daughter to be able to get the cheaper drug.
-
With drug costs on the rise — and insurers refusing to cover some prescriptions — even patients with insurance can find themselves facing high out-of-pocket costs or going without.
-
Skyrocketing prices of insulin in recent years have increased medical costs for the millions of people living with diabetes around the country and in…
-
Lawmakers are back on Capitol Hill on Monday after an extended summer recess. Debates on gun control, prescription drugs and trade are expected, but bipartisan cooperation on those are elusive.
-
Florida’s initial effort to gauge interest in the operation of a Canadian drug importation program has drawn more letters of concern from critics than...
-
A new law would let the state make bulk purchases of prescription drugs from Canada. But it still faces hurdles that could keep it from becoming reality.
-
Floridians spend a lot on prescription drugs -- more than $30 billion last year, according to the Kaiser Family Foundation. Now at least some Florida…
-
A Senate health care panel ran out of time Thursday and was unable to consider a measure aimed at allowing imported prescription drugs from Canada.
-
A Senate hearing on Tuesday featuring pharmaceutical executives will tackle many issues raised in the historic Kefauver hearings, which led to tougher drug regulation. High prices remain a concern.